Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients with Severe Persistent Allergic Asthma: Its Relation To Omalizumab Treatment


Yalcin A. D. , Gorczynski R. M. , Parlak G. E. , Kargi A., Bisgin A. , Sahin E., ...Daha Fazla

CLINICAL LABORATORY, cilt.58, ss.89-96, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 58
  • Basım Tarihi: 2012
  • Dergi Adı: CLINICAL LABORATORY
  • Sayfa Sayıları: ss.89-96

Özet

Background: Asthma is a chronic inflammatory disease and omalizumab is indicated for moderate-to-severe persistent asthma. The results of many studies have shown that oxidative stress is involved in asthma pathogenesis. However, there is no data available to evaluate the alterations in total antioxidant capacity, hydrogen peroxide, malondialdehyde, and total nitric oxide concentrations.